These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2164839)

  • 1. Serum levels of soluble CD30 molecule (Ki-1 antigen) in Hodgkin's disease: relationship with disease activity and clinical stage.
    Pizzolo G; Vinante F; Chilosi M; Dallenbach F; Josimovic-Alasevic O; Diamantstein T; Stein H
    Br J Haematol; 1990 Jun; 75(2):282-4. PubMed ID: 2164839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's disease.
    Gause A; Pohl C; Tschiersch A; Da Costa L; Jung W; Diehl V; Hasenclever D; Pfreundschuh M
    Blood; 1991 May; 77(9):1983-8. PubMed ID: 1850308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin's disease and correlate with clinical features and prognosis.
    Nadali G; Vinante F; Ambrosetti A; Todeschini G; Veneri D; Zanotti R; Meneghini V; Ricetti MM; Benedetti F; Vassanelli A
    J Clin Oncol; 1994 Apr; 12(4):793-7. PubMed ID: 8151321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum level of the soluble form of the CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcome.
    Nadali G; Tavecchia L; Zanolin E; Bonfante V; Viviani S; Camerini E; Musto P; Di Renzo N; Carotenuto M; Chilosi M; Krampera M; Pizzolo G
    Blood; 1998 Apr; 91(8):3011-6. PubMed ID: 9531614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of the soluble form of CD30 molecule as a tumor marker in CD30+ anaplastic large-cell lymphoma.
    Nadali G; Vinante F; Stein H; Todeschini G; Tecchio C; Morosato L; Chilosi M; Menestrina F; Kinney MC; Greer JP
    J Clin Oncol; 1995 Jun; 13(6):1355-60. PubMed ID: 7751879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble CD8, CD25 and CD30 antigens as prognostic markers in patients with untreated Hodgkin's lymphoma.
    Gause A; Jung W; Schmits R; Tschiersch A; Scholz R; Pohl C; Hasenclever D; Diehl V; Pfreundschuh M
    Ann Oncol; 1992 Sep; 3 Suppl 4():49-52. PubMed ID: 1333270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunophenotype of Reed-Sternberg cells. A study of 50 cases of Hodgkin's disease using fixed frozen tissues.
    Agnarsson BA; Kadin ME
    Cancer; 1989 Jun; 63(11):2083-7. PubMed ID: 2566368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD30 ligand in lymphoma patients with CD30+ tumors.
    Younes A; Consoli U; Snell V; Clodi K; Kliche KO; Palmer JL; Gruss HJ; Armitage R; Thomas EK; Cabanillas F; Andreeff M
    J Clin Oncol; 1997 Nov; 15(11):3355-62. PubMed ID: 9363866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of a soluble form of the CD30 antigen in sera of patients with lymphoma, adult T-cell leukemia and infectious mononucleosis.
    Pfreundschuh M; Pohl C; Berenbeck C; Schroeder J; Jung W; Schmits R; Tschiersch A; Diehl V; Gause A
    Int J Cancer; 1990 May; 45(5):869-74. PubMed ID: 2159438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shedding of the soluble form of CD30 from the Hodgkin-analogous cell line L540 is strongly inhibited by a new CD30-specific antibody (Ki-4).
    Horn-Lohrens O; Tiemann M; Lange H; Kobarg J; Hafner M; Hansen H; Sterry W; Parwaresch RM; Lemke H
    Int J Cancer; 1995 Feb; 60(4):539-44. PubMed ID: 7530238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble CD30: a possible serum tumor marker for primary effusion lymphoma.
    Michai M; Goto H; Hattori S; Vaeteewoottacharn K; Wongkham C; Wongkham S; Okada S
    Asian Pac J Cancer Prev; 2012; 13(10):4939-41. PubMed ID: 23244086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human macrophages can express the Hodgkin's cell-associated antigen Ki-1 (CD30).
    Andreesen R; Brugger W; Löhr GW; Bross KJ
    Am J Pathol; 1989 Jan; 134(1):187-92. PubMed ID: 2536522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD30 expression utilization for the accuracy of classical Hodgkin's lymphoma staging.
    Flangea C; Potencz E; Mihăescu R; Anghel A; Gîju S; Motoc M; Dogaru C
    Rom J Morphol Embryol; 2006; 47(2):113-7. PubMed ID: 17106517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of cellular markers in Epstein-Barr virus-positive Hodgkin's disease.
    Bai MC; Jiwa NM; Horstman A; Vos W; Kluin PH; Van der Valk P; Mullink H; Walboomers JM; Meijer CJ
    J Pathol; 1994 Sep; 174(1):49-55. PubMed ID: 7525910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo targeting of Hodgkin and Reed-Sternberg cells of Hodgkin's disease with monoclonal antibody Ber-H2 (CD30): immunohistological evidence.
    Falini B; Flenghi L; Fedeli L; Broe MK; Bonino C; Stein H; Dürkop H; Bigerna B; Barbabietola G; Venturi S
    Br J Haematol; 1992 Sep; 82(1):38-45. PubMed ID: 1329918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of circulating ICAM-1 are increased in Hodgkin's disease.
    Gruss HJ; Dölken G; Brach MA; Mertelsmann R; Herrmann F
    Leukemia; 1993 Aug; 7(8):1245-9. PubMed ID: 8102418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of EBV encoded latent membrane protein 1 (LMP-1) and bcl-2 protein in childhood and adult Hodgkin's disease: application of microwave irradiation for antigen retrieval.
    Kaczorowski S; Kaczorowska M; Christensson B
    Leuk Lymphoma; 1994 Apr; 13(3-4):273-83. PubMed ID: 7914127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an Mr 70,000 antigen associated with Reed-Sternberg cells and interdigitating reticulum cells.
    Hsu PL; Hsu SM
    Cancer Res; 1990 Jan; 50(2):350-7. PubMed ID: 2153049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble ICAM-1 in Hodgkin's disease: a promising independent predictive marker for survival.
    Christiansen I; Enblad G; Kälkner KM; Gidlöf C; Glimelius B; Tötterman TH
    Leuk Lymphoma; 1995 Oct; 19(3-4):243-51. PubMed ID: 8535215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-dependent changes of serum soluble CD30 concentration in children.
    Chrul S; Polakowska E
    Pediatr Transplant; 2011 Aug; 15(5):515-8. PubMed ID: 21672104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.